睾酮与红细胞寿命
研究使用无创方法评估性腺功能减退或跨性别男性在睾酮治疗前及治疗后18周内的红细胞寿命,并在小鼠中验证雄激素对红细胞寿命的影响。结果显示,治疗前患者红细胞寿命显著降低,睾酮治疗6周时红细胞寿命增加但18周时回落至治疗前水平,而血清睾酮和血红蛋白持续升高。
要点
- 性腺功能减退和跨性别男性治疗前红细胞寿命较对照组显著降低。
- 睾酮治疗6周时红细胞寿命增加,但18周时回落至治疗前水平。
- 睾酮治疗使血清睾酮和血红蛋白持续升高至18周。
核心结论
- 性腺功能减退男性红细胞寿命降低,雄激素诱导的循环红细胞寿命急性增加可能有助于雄激素已知的促红细胞生成效应,但长期效应需进一步研究以确定其对雄激素诱导的循环血红蛋白增加的贡献程度。
研究设计与样本
- 在性腺功能减退或跨性别男性中,于开始睾酮治疗前及治疗后最长18周内,使用肺泡一氧化碳浓度和血血红蛋白按Levitt公式估算红细胞寿命。
- 在雄激素受体敲除和野生型小鼠中,对完整雌性或去势雄性小鼠给予睾酮或DHT后,使用体内生物素标记红细胞表面表位(网织红细胞Ter119+CD71+和红细胞标志物CD45-、Ter119+CD71-),通过流式细胞术监测其血液消失率来估算红细胞寿命。
主要发现
- 治疗前,性腺功能减退和跨性别男性的红细胞寿命较对照组显著降低。
- 睾酮治疗6周时红细胞寿命增加,但18周时回落至治疗前水平,而血清睾酮和血血红蛋白在18周时仍保持升高。
- 在小鼠中,睾酮和DHT治疗使红细胞寿命(而非网织红细胞寿命)更高,但去势或雄激素受体失活均未显著影响红细胞或网织红细胞寿命。
临床怎么用
- 原文未据此给出推荐。
局限性
- 长期效应需进一步研究以确定其对雄激素诱导的循环血红蛋白增加的贡献程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Endogenous and exogenous androgens increase circulating erythrocytes and hemoglobin but their effects on erythrocyte lifespan is not known. OBJECTIVE: To investigate androgen effects on immature and mature erythrocyte lifespan in humans and mice using novel nonradioactive minimally invasive methods. DESIGN: Human erythrocyte lifespan was estimated using alveolar carbon monoxide concentration and blood hemoglobin in Levitt's formula in hypogonadal or transgender men before and up to 18 weeks after commencing testosterone (T) treatment. Erythrocyte lifespan was estimated in androgen receptor knockout and wild-type mice after T or DHT treatment of intact females or orchidectomized males using in vivo biotin labelling of erythrocyte surface epitopes for reticulocytes (Ter119+CD71+) and 2 markers of erythrocytes (CD45-, Ter119+CD71-) monitoring their blood disappearance rate by flow cytometry. RESULTS: Before treatment, hypogonadal and transgender men had marked reduction in erythrocyte lifespan compared with controls. T treatment increased erythrocyte lifespan at 6 weeks but returned to pretreatment levels at 18 weeks, whereas serum T and blood hemoglobin were increased by T treatment remaining elevated at 18 weeks. In mice, T and DHT treatment had higher erythrocyte (but not reticulocyte) lifespan but neither orchidectomy nor androgen receptor inactivation significantly influenced erythrocyte or reticulocyte lifespan. CONCLUSION: We conclude that hypogonadal men have reduced erythrocyte lifespan and acute androgen-induced increase in circulating erythrocyte lifespan may contribute to the well-known erythropoietic effects of androgens, but longer term effects require further investigation to determine how much they contribute to androgen-induced increases in circulating hemoglobin.
引用
- McMartin MC, Savkovic S, Romano A, et al. Testosterone and Erythrocyte Lifespan. J Clin Endocrinol Metab. 2024. PMID: 38912796. doi:10.1210/clinem/dgae434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。